Skip to content
10-K/A

Annual Report

PROVECTUS BIOPHARMACEUTICALS, INC. PVCT

0001641172-25-011210

← back to feed
Filed
May 16, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 25, 2025 420.28M sh